The Cigna Group (NYSE:CI – Get Rating) Director Donna F. Zarcone sold 2,088 shares of The Cigna Group stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $271.67, for a total transaction of $567,246.96. Following the completion of the sale, the director now directly owns 25,550 shares in the company, valued at approximately $6,941,168.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
The Cigna Group Stock Down 0.3 %
Shares of NYSE:CI opened at $272.13 on Wednesday. The Cigna Group has a 52-week low of $227.94 and a 52-week high of $340.11. The firm has a fifty day moving average of $298.52 and a 200 day moving average of $304.99. The firm has a market capitalization of $80.84 billion, a PE ratio of 12.73, a price-to-earnings-growth ratio of 0.99 and a beta of 0.67. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.70 and a current ratio of 0.70.
The Cigna Group (NYSE:CI – Get Rating) last announced its earnings results on Friday, February 3rd. The health services provider reported $4.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.84 by $0.12. The Cigna Group had a net margin of 3.69% and a return on equity of 16.01%. The company had revenue of $45.75 billion during the quarter, compared to analyst estimates of $45.79 billion. During the same period in the previous year, the business earned $4.77 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. As a group, research analysts anticipate that The Cigna Group will post 24.65 EPS for the current fiscal year.
The Cigna Group Increases Dividend
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on the stock. Stephens reaffirmed an “overweight” rating and issued a $370.00 price target on shares of The Cigna Group in a report on Tuesday, February 28th. StockNews.com cut shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 28th. Wells Fargo & Company cut shares of The Cigna Group from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $370.00 to $355.00 in a report on Tuesday, January 3rd. JPMorgan Chase & Co. lowered their target price on shares of The Cigna Group from $378.00 to $370.00 and set an “overweight” rating on the stock in a report on Thursday, February 23rd. Finally, Raymond James lowered their target price on shares of The Cigna Group from $370.00 to $350.00 and set an “outperform” rating on the stock in a report on Tuesday, February 7th. Seven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $339.00.
Institutional Trading of The Cigna Group
Hedge funds have recently added to or reduced their stakes in the business. Householder Group Estate & Retirement Specialist LLC bought a new stake in The Cigna Group in the third quarter worth $34,000. RFG Advisory LLC raised its stake in shares of The Cigna Group by 13.0% during the second quarter. RFG Advisory LLC now owns 1,697 shares of the health services provider’s stock valued at $478,000 after acquiring an additional 195 shares during the last quarter. Sigma Planning Corp raised its stake in shares of The Cigna Group by 1.4% during the third quarter. Sigma Planning Corp now owns 4,711 shares of the health services provider’s stock valued at $1,307,000 after acquiring an additional 65 shares during the last quarter. Creative Planning raised its stake in shares of The Cigna Group by 3.7% during the second quarter. Creative Planning now owns 33,692 shares of the health services provider’s stock valued at $8,879,000 after acquiring an additional 1,196 shares during the last quarter. Finally, Trust Co. of Vermont raised its stake in shares of The Cigna Group by 33.5% during the third quarter. Trust Co. of Vermont now owns 7,838 shares of the health services provider’s stock valued at $2,174,000 after acquiring an additional 1,967 shares during the last quarter. 87.61% of the stock is owned by institutional investors.
The Cigna Group Company Profile
The Cigna Group is engaged in the provision of global health services. It operates through the following segments: Evernorth, U.S. Medical, International Markets, and Group Disability and Other. The Evernorth segment includes a broad range of coordinated and point solution health services, including pharmacy solutions, benefits management solutions, care solutions and intelligence solutions.
- Get a free copy of the StockNews.com research report on The Cigna Group (CI)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.